Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

View source ↗

Summary

Clinical trial registry update for the RUBIN platform extension focusing on hematologic malignancies. It is currently recruiting for conditions including Chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: iOMEDICO AG | Conditions: Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL) | Status: RECRUITING